Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER)
|
|
|
- Antony Shepherd
- 7 years ago
- Views:
Transcription
1 Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) David R. Hopkins KASPER Program Manager Office of Inspector General Kentucky Cabinet for Health and Family Services BJA PDMP South Region Meeting April 29, 2014
2 The Political Climate Opioid abuse a national epidemic Controlled substance abuse increasing Kentucky opioid misuse rate tied for 2 nd highest in nation Opioid overdose deaths increasing Kentucky opioid overdose death rate 6 th highest in nation Legislators viewed medical community as not addressing the problem Cabinet for Health and Family Services
3 Total Number Drug Overdose Deaths in Kentucky Kentucky Resident Drug Overdose Deaths, ,022 1, Produced by the Kentucky Injury Prevention and Research Center, January Data source: Kentucky Vital Statistics electronic death certificate file. Data for are provisional and subject to change. Cabinet for Health and Family Services
4 Drug Overdose Death Rates in Kentucky Cabinet for Health and Family Services
5 Controlled Substance Usage 2013 Cabinet for Health and Family Services
6 KASPER Usage December 31, 2011 Pharmacists = 3.5% (26% of KY pharmacists had accounts) Law Enforcement = 1.5% (13% of KY LE had accounts) Judges, Other =.1% Prescribers = 94.9% (32% of KY prescribers had accounts) Cabinet for Health and Family Services
7 The Legislature Passed mandatory KASPER registration and usage legislation: 2012 House Bill 1 Pill Mill Bill 2013 House Bill 217 Cabinet for Health and Family Services
8 ekasper Reporting KRS 218A.202 Controlled substance administration or dispensing must be reported within one day effective July 1, 2013 Cabinet for Health and Family Services
9 ekasper Accounts KRS 218A.202 ekasper registration is mandatory for Kentucky practitioners or pharmacists authorized to prescribe or dispense controlled substances to humans. Cabinet for Health and Family Services
10 ekasper Prescriber Usage - KRS 218A.172 Query ekasper for previous 12 months of data: Prior to initial prescribing or dispensing of a Schedule II controlled substance, or a Schedule III controlled substance containing hydrocodone No less than every three months Review data before issuing a new prescription or refills for a Schedule II controlled substance or a Schedule III controlled substance containing hydrocodone Additional rules/exceptions included in licensure board regulations Cabinet for Health and Family Services
11 KASPER Regulations Licensure Boards 201 KAR 5:130 Kentucky Board of Optometric Examiners KASPER requirements 201 KAR 8:540 Kentucky Board of Dentistry KASPER requirements 201 KAR 9:260 Kentucky Board of Medical Licensure KASPER requirements 201 KAR 20:057 Kentucky Board of Nursing KASPER requirements 201 KAR 25:090 Kentucky Board of Podiatry KASPER requirements. Justice & Public Safety Cabinet
12 Exceptions After surgery Patients in hospitals and long term care facilities Hospitals and long term care facilities can establish facility accounts and request reports on behalf of the facility Patients in Hospice care or being treated for cancer pain Single doses of anxiety medicine prior to a procedure As a substitute within 7 days of initial prescribing Cabinet for Health and Family Services
13 Implementation Challenges
14 Prescriber and Pharmacist Registration Implemented temporary paperless registration process Increased administrative staff to handle s and calls Went from one to three administrative staff Engaged four temps Cabinet for Health and Family Services
15 KASPER Master Accounts 12/31/ /24/ /20/ /24/2014 Doctor* 5,470 5,680 11,923 17,807 APRN ,523 2,150 Pharmacist 1,385 1,450 3,602 5,363 Total 7,545 7,911 17,048 25,320 *Includes physicians, dentists, optometrists and podiatrists Cabinet for Health and Family Services
16 Technology Challenges Less than three months to prepare Had to rely on existing system capacity Initial system outages Increased technology Help Desk staff from one to four Created web-based KASPER tutorial Cabinet for Health and Family Services
17 Cabinet for Health and Family Services KASPER Reports
18 Cabinet for Health and Family Services Policy Challenges Complexity of 2012 licensure board regulations Simplified in 2013 Confusion on who to contact with questions/issues KASPER Licensure Boards Proliferation of misinformation HB1 Legislative Oversight Committee
19 Results
20 Controlled Substance Dispensing One Year Comparison Drug August 2011 through July 2012 Cabinet for Health and Family Services August 2012 through July 2013 Change Hydrocodone 239,037, ,349, % Oxycodone 87,090,503 77,022, % Oxymorphone 1,753,231 1,138, % Alprazolam 71,669,411 62,088, % Methylphenidate 10,659,840 11,454, % Amphetamine 13,795,147 15,065, % All Controlled Substances 739,263, ,303, % Figures shown in doses dispensed
21 Cabinet for Health and Family Services Hydrocodone
22 Cabinet for Health and Family Services Oxycodone
23 Cabinet for Health and Family Services Alprazolam
24 Cabinet for Health and Family Services Methadone
25 Cabinet for Health and Family Services Oxymorphone
26 Cabinet for Health and Family Services Tramadol
27 Cabinet for Health and Family Services Buprenorphine
28 Cabinet for Health and Family Services Buprenorphine
29 House Bill 1 Impact Study Comprehensive assessment of HB1 s impact on patients, prescribers, and other stakeholders Overall goals: Evaluate the impact of HB1 on reducing prescription drug abuse and diversion in Kentucky Identify unintended consequences associated with implementation of HB1 that impact patients, providers and citizens of the Commonwealth Develop recommendations to improve effectiveness of HB1 and mitigate identified unintended consequences Final study report planned for July 2014 Cabinet for Health and Family Services
30 David R. Hopkins Kentucky Cabinet for Health and Family Services 275 East Main Street, 5ED Frankfort, KY ext KASPER Web Site:
Kentucky All Schedule Prescription Electronic Reporting: Data Collection/User Training
Kentucky All Schedule Prescription Electronic Reporting: Data Collection/User Training David R. Hopkins KASPER Project Manager Office of Inspector General National Meeting on PDMP Legislation and Implementation
Mandating PDMP participation by medical providers: current status and experience in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing Mandating PDMP participation by medical providers: current status and experience in selected states Revision 1, February
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
American Indian Health Commission for Washington State October 1, 2015
American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.
Prescribers required to check PDMP before first prescription for Controled Substances for new patient.
State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
Prescription Drug Monitoring Program. A Powerful Tool
Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose
PRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
How To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
Alaska Prescription Drug Monitoring Program
Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program
Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department
2010-2011 Prescription Drug Monitoring Program Annual Report
2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription
Kentucky All Schedule Prescription Electronic Reporting (KASPER)
Kentucky All Schedule Prescription Electronic Reporting (KASPER) A Comprehensive Report on Kentucky s Prescription Monitoring Program Prepared by the Cabinet for Health and Family Services Office of the
For a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs
The Council of State governments CAPITOL research APRIL 00 Prescription Drug Monitoring Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State Governments Misuse of
Prescription Drug Monitoring Programs Bill Status Update
Prescription Drug Monitoring Programs Bill Status Update Research current through February 24, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle
Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,
The Prescription Drug Abuse and Heroin Crisis: New York s Response
The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid
Prescription Drug Abuse Florida s Health Crisis
Prescription Drug Abuse Florida s Health Crisis Overview Florida has been the epicenter for the diversion and abuse of prescription drugs. Prescription drugs killed almost 7 Floridians per day after an
Trends of Opioid Misuse and Diversion: Lessons from the United States
Trends of Opioid Misuse and Diversion: Lessons from the United States 31 October 2012 Richard C. Dart, MD, PhD Director Rocky Mountain Poison and Drug Center Professor - University of Colorado, Department
Prescription Opioid Overdose & Misuse in Oregon
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing
Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly
Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly Andrea Huddleston, Chief Deputy General Counsel Tennessee Department of Health Office of General
Pennsylvania s ABC-MAP Program
Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia
CURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
THE LAWS AND REGULATIONS ON APRN PRESCRIPTIVE AUTHORITY
THE LAWS AND REGULATIONS ON APRN PRESCRIPTIVE AUTHORITY KRS 314.011(8) "Advanced practice registered nursing" means the performance of additional acts by registered nurses who have gained added knowledge
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis Grant Baldwin, PhD, MPH February 2, 2016 National Center for Injury Prevention and Control Division of Unintentional Injury
Maximizing Use of Prescription Drug Monitoring Programs
Maximizing Use of Prescription Drug Monitoring Programs Christopher M..Jones, PharmD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease
The Role of Prescription Drug Monitoring Programs in Combatting Controlled Substance Abuse
The Role of Prescription Drug Monitoring Programs in Combatting Controlled Substance Abuse Amanda J. Ward, PharmD, CGP Pharmacist Consultant Drug Enforcement and Professional Practices Branch Office of
Prescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
Sample Patient Agreement Forms
Sample Patient Agreement Forms Introduction This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory
Ohio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
New Mexico. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us
Implementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin
Technical Assistance Guide No. 04-13 Funding Options for Prescription Drug Monitoring Programs
Technical Assistance Guide No. 04-13 Funding Options for Prescription Drug Monitoring Programs July 3, 2013 Introduction Over the past ten years, prescription drug monitoring programs (PDMPs) have proliferated
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
Massachusetts. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted
Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon
Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon Dwight Holton Chief Executive Officer Lines for Life 971-244-1370 DwightH@linesforlife.orrg Page 1 of 21 14 Masters
11/26/2012. Implementation of Florida s PDMP. Disclosure
Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
Arkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
Drug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
Independent Evaluation of the Impact and Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER)
Independent Evaluation of the Impact and Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER) KASPER Evaluation Team* Institute for Pharmaceutical Outcomes and
JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature
RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC
RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC 2014 Report of Best Practices Joint Policy Working Group With the goal of reducing diversion, abuse and addiction and protecting access for
Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee:
Testimony Joint Senate and Assembly Health and Human Services Committee Wednesday, April 1, 2015 3:30 p.m. SB 459 Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee: My name is Linda
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,
What Parents Need to Know
What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to
Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER
Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,
Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse
Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse Jodi Manz, MSW Policy Advisor Office of the Secretary of Health and Human Resources October 7, 2015 Rates of of Opioid
Drug Courts and PDMPs M A Y 1 4, 2 0 1 4
Drug Courts and PDMPs M A Y 1 4, 2 0 1 4 Disclaimer Language of the drug court field can be confusing. Terms Drug court, problem solving court and specialty court are sometimes used interchangeably by
Florida s Claim to Fame: Pain Clinics and Narcotic Fraud
Florida s Claim to Fame: Pain Clinics and Narcotic Fraud Dr. Cheryl A. Lindo, PharmD Miami VA Medical Center Miami, FL January 20, 2012 Objectives Highlight Florida s pharmaceutical trends Review diversion
Brief History of the Kentucky Board of Nursing
Brief History of the Kentucky Board of Nursing 1914 The Kentucky Board of Nursing was created and called: The Kentucky State Board of Trained Nurses. Five Board members were appointed by the Governor from
2. PRESCRIPTION DRUG MONITORING PROGRAMS (PDMPs)
NATIONAL CONFERENCE OF INSURANCE LEGISLATORS (NCOIL) PROPOSED BEST PRACTICES TO ADDRESS OPIOID ABUSE, MISUSE & DIVERSION To be considered by the NCOIL Workers Compensation Insurance Committee on July 12,
REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1381 Prescription Drug Monitoring Program SPONSOR(S): Davis TIED BILLS: IDEN./SIM. BILLS: REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF
Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
Prescription Drug Monitoring Programs: Evaluation of Effectiveness
Prescription Drug Monitoring Programs: Evaluation of Effectiveness Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Denver Health and Hospital Authority Associate Professor, Department
1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve?
RI Mental Health Summit Lightning Round Q&A s June 8, 2015 Opiate Addiction Epidemic 1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve? 2) What would
INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS
INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND DISCLOSURE SHERRY L. GREEN, CEO NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS NATIONAL CONFERENCE OF
Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC
Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy
Options for Unsolicited Reporting
Prescription Drug Monitoring Program Center of Excellence at Brandeis Guidance on PDMP Best Practices BP 01 Options for Unsolicited Reporting January, 2014 This project was supported by Grant No. 2011-PM-BX-K002
State of New York Executive Chamber Andrew M. Cuomo Governor
State of New York Executive Chamber Andrew M. Cuomo Governor For Immediate Release: August 27, 2012 GOVERNOR CUOMO SIGNS LEGISLATION TO HELP NEW YORK STATE FIGHT PRESCRIPTION DRUG ABUSE Governor Andrew
A Multi-Systemic Approach for Reducing Health and Criminal Justice Consequences Pinal County Year 1 Progress
The Arizona Prescription Drug Misuse and Abuse Initiative A Multi-Systemic Approach for Reducing Health and Criminal Justice Consequences Pinal County Year 1 Progress Evaluation: Conceptual Framework Expected
Washington. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington
Prescription Drug Monitoring Program Center of Excellence at Brandeis
Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers
Division II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015
Division II Medical/Pharmaceutical Services, Education and Oversight Carson (Thursday) 12/14/2015 Topic -Division II Expanding Board of Medicine; including practitioner of pain medicine or anesthesiology
The Massachusetts Prescription Monitoring Program
The Massachusetts Prescription Monitoring Program A Report to the Massachusetts General Court February 2015 Governor Charles D. Baker Secretary of Health and Human Services Marylou Sudders Massachusetts
Summary of Children s Safety Network Prescription and Over-the-Counter Drug Abuse Environmental Scan
Summary of Children s Safety Network Prescription and Over-the-Counter Drug Abuse Environmental Scan Introduction Prescription and over-the-counter (OTC) drug abuse and its consequences are a fast growing
Mayor s Task Force On Prescription Painkiller Abuse
Mayor s Task Force On Prescription Painkiller Abuse Interim Report January 2013 BACKGROUND In response to a growing epidemic, in late 2011 Mayor Bloomberg created the multi-agency Task Force on Prescription
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Enhancing Access to Prescription Drug Monitoring Programs Using Health Information Technology: Work Group Recommendations
Prepared for Office of the National Coordinator for Health Information Technology, in partnership with the Substance Abuse and Mental Health Services Administration Enhancing Access to Prescription Drug
What Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry
State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry Cliff Bersamira, Research Analyst Rick Harwood, Research and Program Applications Director National
Mid-Level Practitioners Authorization by State
Mid-Level Practitioners Authorization by State Pursuant to Title 21, Code of Federal Regulations, Section 1300.01(b28), the term mid-level practitioner means an individual practitioner, other than a physician,
314.042 License to practice as an advanced practice registered nurse -- Application -- Renewal -- Reinstatement -- Use of "APRN" -- Prescriptive
314.042 License to practice as an advanced practice registered nurse -- Application -- Renewal -- Reinstatement -- Use of "APRN" -- Prescriptive authority under CAPA-NS and CAPA-CS -- Exemption from CAPA-NS
Statement of the Federation of State Medical Boards of the United States
Statement of the Federation of State Medical Boards of the United States Introduction Drug Enforcement Agency Hearing on Electronic Prescriptions for Controlled Substances Presented by Lisa A. Robin Vice
North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances
North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances Final Report to the Joint Legislative Program Evaluation Oversight Committee Report
Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy
Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.
Prescription Medication Abuse: Skills for Prevention and Intervention
Prescription Medication Abuse: Skills for Prevention and Intervention icare Partnership www.icarenc.org James Finch, MD North Carolina Society of Addiction Medicine NC Governor s Institute on Alcohol and
FACT SHEET FOR HEALTH CARE PRACTITIONERS
Florida s Prescription Drug Monitoring Program http://www.e-forcse.com FACT SHEET FOR HEALTH CARE PRACTITIONERS The Florida Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic- Florida
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department
Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:
CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.
Roadmap. Florida Trends in Prescription Drug Abuse. Oath of a Pharmacist. Plantation Chemist Busted
Florida Trends in Prescription Drug Abuse Jennifer A. Fass, PharmD, CPh Clinical Assistant Professor fass@nova.edu Roadmap Discuss Florida Medical Examiners Report Illustrate prescription drug abuse cases
Texas Board of Nursing Update
Texas Board of Nursing Update Texas Organization of Nurse Executives Annual Conference April 4, 2014 Kristin Benton, MSN, RN Director of Nursing Texas Board of Nursing Objectives 1. Discuss national changes
How To Understand The Ppa
MTION OF STATE PREPTION NITONG PROGRAM PS This project was supported by Cooperative Agreement No. 202-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component
Our Mission. How does Colorado Medicaid Work? Objectives
How does Colorado Medicaid Work? Understanding the Delivery of Pharmaceutical Care Cathy Traugott, JD, RPh Client and Clinical Care Office Pharmacy Unit Manager Department of Health Care Policy and Financing